Jing Zhou

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 296 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission

Jing Zhou, Guobing� Li, Yi Zheng et al. · Autophagy · 2015 · 255 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction

Yosup Rew, Daqing Sun, Felix González-López de Turiso et al. · Journal of Medicinal Chemistry · 2012 · 169 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Spectroscopic Studies of Substrate Interactions with Clavaminate Synthase 2, a Multifunctional α-KG-Dependent Non-Heme Iron Enzyme:  Correlation with Mechanisms and Reactivities

Jing Zhou, Wendy L. Kelly, Brian O. Bachmann et al. · Journal of the American Chemical Society · 2001 · 150 citations

Life Sciences, Biochemistry, Chemistry +16

Circular Dichroism and Magnetic Circular Dichroism Spectroscopic Studies of the Non-Heme Ferrous Active Site in Clavaminate Synthase and Its Interaction with α-Ketoglutarate Cosubstrate

Elizabeth G. Pavel, Jing Zhou, Robert Busby et al. · Journal of the American Chemical Society · 1998 · 148 citations

Life Sciences, Biochemistry, Enzymology +12